Frontlight ResearchEarly access
Trial site
NYU Langone Health- Long Island
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Lung cancer2 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Multiple myeloma1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 12 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting2 trials
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Janux Therapeutics1 trial
- NYU Langone Health1 trial
Running trials
Not yet recruiting
Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
Recruiting
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Active, not recruiting
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026